|
Market Closed -
CBOE
11:30:00 2026-09-11 am EDT
|
Pre-market 02:08:30 am | |||
| 3.170 EUR | 0.00% |
|
2.988 | -5.74% |
| Sep. 09 | Evotec Initiates Phase 1 Trial of Potential Smallpox, Mpox Treatment | MT |
| Sep. 09 | Evotec Commences Early-stage Study of Potential Orthopoxvirus Therapy | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 688.17 | +29.55% | 23 | ||||||
| 251.21 | +23.28% | 20 | ||||||
| 276.28 | +5.54% | 18 | ||||||
| 432.8 | +24.9% | 28 | ||||||
| 268,232.21 | +50.52% | 22 | ||||||
| 270.71 | +19.38% | 20 | ||||||
| 581.83 | -0.97% | 12 | ||||||
| 72.24 | +2.18% | 14 | ||||||
| 282.43 | +1.5% | 14 | ||||||
| 185.56 | +9.6% | 16 | ||||||
| 70.73 | -1.93% | 11 | ||||||
| 68.18 | +15.53% | 17 | ||||||
| 137.98 | +36.2% | 7 | ||||||
| 50.33 | +24.94% | 11 | ||||||
| 174.69 | +17.89% | 13 | ||||||
| 136.77 | +18.97% | 22 | ||||||
| 638.68 | +90.89% | 19 | ||||||
| 3.908 | -5.27% | 7 | ||||||
| 84.23 | +55.37% | 22 | ||||||
| Average | 14,349.42 | +22.01% | 17 | ||||||
| Weighted average by Cap. | 23,627.18 | +22.11% | 19 |
- Stock Market
- Stocks
- EVT Stock
- 0IRF Stock
- Sector Evotec SE
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
